The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Prostaglandin E2 Induces Degranulation-Independent Production of Vascular Endothelial Growth Factor by Human Mast Cells
Abstract
Mast cells accumulate in large numbers at angiogenic sites, where they have been shown to express a number of proangiogenic factors, including vascular endothelial growth factor (VEGF-A). PGE2 is known to strongly promote angiogenesis and is found in increased levels at sites of chronic inflammation and around solid tumors. The expression pattern of VEGF and the regulation of VEGF-A by PGE2 were examined in cord blood-derived human mast cells (CBMC). CBMC expressed mRNA for five isoforms of VEGF-A and other members of the VEGF family (VEGF-B, VEGF-C, and VEGF-D) with strong expression of the most potent secretory isoforms. PGE2 was a very strong inducer of VEGF-A121/165 production by CBMC and also elevated VEGF-A mRNA expression. The amount of VEGF-A121/165 protein production induced by PGE2 was 4-fold greater than that induced by IgE-mediated activation of CBMC. Moreover, the response to PGE2 as well as to other cAMP-elevating agents such as forskolin and salbutamol was observed under conditions that were not associated with mast cell degranulation. CBMC expressed substantial levels of the EP2 receptor, but not the EP4 receptor, when examined by flow cytometry. In contrast to other reported PGE2-mediated effects on mast cells, VEGF-A121/165 production occurred via activation of the EP2 receptor. These data suggest a role for human mast cells as a potent source of VEGF121/165 in the absence of degranulation, and may provide new opportunities to regulate angiogenesis at mast cell-rich sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prostanoid Receptors: Subtypes and Signaling
Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.661 · Cited by 1,011
Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
Coussens, L. M., Raymond, W. W., Bergers, G., Laig-Webster, M., Behrendtsen, O., Werb, Z., Caughey, G. H., & Hanahan, D. (1999) · Genes & Development · doi:10.1101/gad.13.11.1382 · Cited by 946 · cited 1×
“Much of the mast cell’s proangiogenic activity is thought to result from mast cell production of proangiogenic products, including matrix metalloproteinase 9 (9), fibroblast growth factor-2 (13), IL-8 (14), and the most potent proangiogenic mediator vascular endothelial growth factor (VEGF) (15).”
BackgroundESTROGEN REGULATES CYTOKINE RELEASE IN HUMAN MAST CELLS
Kim, M.-S., Chae, H.-J., Shin, T.-Y., Kim, H.-M., & Kim, H.-R. (2001) · Immunopharmacology and Immunotoxicology · doi:10.1081/iph-100108596 · Cited by 65
Estrogen receptors in mast cells from arterial walls
NICOVANI, S., & RUDOLPH, M. I. (2002) · BIOCELL · doi:10.32604/biocell.2002.26.015 · Cited by 27
Cited by
Wang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
Regulation of Immune Responses by Prostaglandin E2
Kalinski, P. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101029 · Cited by 1,474
Mast-cell responses to pathogens
Marshall, J. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1460 · Cited by 861
Self-citationNew developments in mast cell biology
Kalesnikoff, J., & Galli, S. J. (2008) · Nature Immunology · doi:10.1038/ni.f.216 · Cited by 748
Mast cells as sources of cytokines, chemokines, and growth factors
Mukai, K., Tsai, M., Saito, H., & Galli, S. J. (2018) · Immunological Reviews · doi:10.1111/imr.12634 · Cited by 682
Metadata
- Authors
- Abdel-Majid, R. M., & Marshall, J. S.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-01
- Volume
- 172
- Issue
- 2
- Pages
- 1227-1236
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1501213833
- Cited by
- 165
- References
- 4
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.